Compassionate Use of Stiripentol in Dravet Syndrome
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01835314 |
Recruitment Status
:
Available
First Posted
: April 18, 2013
Last Update Posted
: April 5, 2017
|
- Study Details
- Tabular View
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Dravet Syndrome | Drug: Stiripentol |
Study Type : | Expanded Access |
Official Title: | Compassionate Use of Stiripentol in Dravet Syndrome |

-
Drug: Stiripentol

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 1 Year to 21 Years (Child, Adult) |
Sexes Eligible for Study: | All |

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01835314
Contact: Kelly Knupp, MD | 720-777-6895 | kelly.knupp@childrenscolorado.org | |
Contact: Alicia M Camuto, BA | 720-777-5514 | alicia.camuto@childrenscolorado.org |
United States, Colorado | |
Children's Hospital Colorado | |
Aurora, Colorado, United States, 80045 | |
Contact: Kelly Knupp, MD 720-777-6895 kelly.knupp@childrenscolorado.org | |
Contact: Alicia Camuto, BA 720-777-5514 alicia.camuto@childrenscolorado.org | |
Principal Investigator: Kelly Knupp, MD |
Principal Investigator: | Kelly Knupp, MD | University of Colorado/Children's Hospital Colorado |
Responsible Party: | University of Colorado, Denver |
ClinicalTrials.gov Identifier: | NCT01835314 History of Changes |
Other Study ID Numbers: |
12-0315 |
First Posted: | April 18, 2013 Key Record Dates |
Last Update Posted: | April 5, 2017 |
Last Verified: | December 2016 |
Additional relevant MeSH terms:
Syndrome Epilepsies, Myoclonic Disease Pathologic Processes Epilepsy |
Brain Diseases Central Nervous System Diseases Nervous System Diseases Stiripentol Anticonvulsants |